SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma

NCT06205316 · clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
118
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Mayo Clinic